Tevard Biosciences
Ben Deverman is the director of the vector engineering research group at the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard. The vector engineering team develops innovative gene delivery solutions for studying the central nervous system, with the aim of uncovering new avenues for treating psychiatric disorders. Deverman joined the Broad in March 2018. Before this, he was the director of the CLARITY, Optogenetics and Vector Engineering Research (CLOVER) Center within the Beckman Institute at the California Institute of Technology.
This person is not in the org chart
This person is not in any offices
Tevard Biosciences
Tevard Biosciences is a biotechnology company pioneering tRNA-based gene therapies to cure rare and severe genetic diseases with limited or no approved treatment options.